Thirdly
President Akufo-Addo: Sustenance of Ghana’s peace is a shared responsibility
President Akufo-Addo says the sustenance of the country’s peace is a shared responsibility for all Ghanaians and has therefore entreated citizens to play their part in keeping the country united even after a fiercely contested election. The President’s comment comes after pockets of violent clashes and vandalism by some elements who feel aggrieved following the declaration of the election results by the chairperson of the Electoral Commission led to a few deaths across the country. Addressing the Muslim community at a thanksgiving service at the Central Mosque in Accra Friday, President Akufo-Addo expressed hope that the Ghanaian people will find a way to come together as one people. “I’m confident that the good sense of the Ghanaian people will make sure that the peace and stability of ou...
eGovernment: NITDA begins capacity building for ministries, agencies
Commonwealth of Nations The National Information Technology Development Agency (NITDA) on Wednesday began a two-day virtual strategic capacity building workshop for federal ministries, departments and agencies (MDAs). The exercise is being carried out to hasten the implementation of the National e-Government Masterplan and inculcate the use of Information Technology in government activities. The training is in three phases for directors of ICT and heads of procurement, network administrators and domain managers, while the third batch is for the NITDA team driving the digital transformation agenda. The Director-General of NITDA, Kashifu Abdullahi, who was represented by the Director e-Government Development and Regulation, Vincent Olatunji, in his opening remarks said the training aims at e...
Coronavirus vaccine breakthrough raises hopes of rapid global rollout
A coronavirus vaccine developed by Britain’s University of Oxford and the pharmaceutical firm AstraZeneca has shown successful results in early trials. If it is approved by regulators, the vaccine appears suitable for a fast rollout around the globe. Early analysis of trials involving 20,000 volunteers in Britain and Brazil show the vaccine is at least 62% effective after two doses. In volunteers given a different dosing regimen — a half dose, followed by a full dose — that figure rose to 90%. The average efficacy of the two dosing methods is 70%. None of those given the vaccine developed severe COVID-19 illness. Andrew Pollard, director of the Oxford Vaccine Group, said the recent successful trials of three different vaccines by Oxford-AstraZeneca, Pfizer-BioNTech and Moderna, represent a...
